News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Mark Salzer, PhD

Articles by Mark Salzer, PhD

AndreyPop/Shutterstock.com

Revisiting the Rationale and Evidence for Peer Support

ByLarry Davidson, PhD,Chyrell Bellamy, MSW, PhD,Mathew Chinman, PhD,Marianne Farkas, ScD,Laysha Ostrow, PhD,Judith A. Cook, PhD,Jessica A. Jonikas, MA,Harvey Rosenthal,Sue Bergeson,Allen S. Daniels, EdD,Mark Salzer, PhD

June 29th 2018

The authors argue that that stating that peer support “lacks evidence” is simply not accurate.

Latest Updated Articles

Revisiting the Rationale and Evidence for Peer Support
June 29th 2018

Trending on Psychiatric Times

FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults